1. Home
  2. ROIV vs TECH Comparison

ROIV vs TECH Comparison

Compare ROIV & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$38.91

Market Cap

28.7B

Sector

Health Care

ML Signal

N/A

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

N/A

Current Price

$72.73

Market Cap

11.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ROIV
TECH
Founded
2014
1976
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.7B
11.4B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
ROIV
TECH
Price
$38.91
$72.73
Analyst Decision
Strong Buy
Hold
Analyst Count
13
13
Target Price
$50.82
★ $70.50
AVG Volume (30 Days)
★ 7.1M
2.8M
Earning Date
11-09-2026
11-06-2026
Dividend Yield
N/A
★ 0.44%
EPS Growth
N/A
★ 152.17
EPS
N/A
★ 0.18
Revenue
$8,260,000.00
★ $1,215,039,000.00
Revenue This Year
$1,870.25
$4.48
Revenue Next Year
$271.46
$10.02
P/E Ratio
★ N/A
$403.89
Revenue Growth
N/A
★ N/A
52 Week Low
$19.96
$43.20
52 Week High
$42.50
$72.88

Technical Indicators

Market Signals
Indicator
ROIV
TECH
Relative Strength Index (RSI) 54.07 52.09
Support Level $33.11 $72.11
Resistance Level $42.37 $72.88
Average True Range (ATR) 1.55 0.12
MACD -0.07 -0.02
Stochastic Oscillator 49.40 39.66

Price Performance

Historical Comparison
ROIV
TECH

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: